Completed PHASE2 INTERVENTIONAL 3-arm NCT05430087

Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patients

The Combination of Vitamin D and Curcumin Piperine Attenuates the Disease Activity and Pro-Inflammatory Cytokines Levels in Systemic Lupus Erythematosus Patients

Sponsor: Saiful Anwar Hospital

Conditions Systemic Lupus Erythematosus

Interventions Observe the clinical outcome and inflammatory cytokines levels in patients with systemic lupus erythematosus (SLE) after being supplemented with Cholecalciferol (Vitamin D3) and Curcumin-Piperine.

Updated 3 times since 2022 Last updated: Jun 21, 2022 Started: Mar 1, 2020 Primary completion: Jan 31, 2022 Completion: Jan 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Systemic Lupus Erythematosus and is currently completed. Saiful Anwar Hospital leads this study, which shows 3 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jul 2022 — Jul 2024 [monthly]

Completed PHASE2

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Saiful Anwar Hospital

Data source: Saiful Anwar Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Malang, Indonesia